Crossref
Lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder: pharmacokinetics, efficacy and safety in children and adolescents
Revista de Psiquiatria Clínica · 2014
DOI: 10.1590/0101-60830000000007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista de Psiquiatria Clínica, 2014. Verfasst von Paulo Mattos. Die Arbeit wurde bisher 4-mal zitiert (Crossref).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Mattos, P. (2014). Lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder: pharmacokinetics, efficacy and safety in children and adolescents. Revista de Psiquiatria Clínica. https://doi.org/10.1590/0101-60830000000007
Vancouver
Mattos P. Lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder: pharmacokinetics, efficacy and safety in children and adolescents. Revista de Psiquiatria Clínica. 2014. doi:10.1590/0101-60830000000007
BibTeX
@article{Mattos2014,
author = {Mattos, Paulo},
title = {Lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder: pharmacokinetics, efficacy and safety in children and adolescents},
journal = {Revista de Psiquiatria Clínica},
year = {2014},
doi = {10.1590/0101-60830000000007}
}
EUVIMED